Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,766.50
Bid: 1,766.00
Ask: 1,766.50
Change: 36.50 (2.11%)
Spread: 0.50 (0.028%)
Open: 1,735.50
High: 1,766.50
Low: 1,735.00
Prev. Close: 1,730.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK Earnings, Trading Statements Calendar - Next 7 Days

Wed, 22nd Jul 2020 15:59

Thursday 23 July 
Tate & Lyle PLCTrading Statement
Unilever PLCHalf Year Results
G4S PLCHalf Year Results
AJ Bell PLCQ3 Results
Countryside Properties PLCHalf Year Results
Brewin Dolphin Holdings PLCQ3 Results
Howden Joinery Group PLCHalf Year Results
Sage Group PLCQ3 Results
RELX PLCHalf Year Results
Daily Mail & General Trust PLCHalf Year Results
Croda International PLCHalf Year Results
IG Group Holdings PLCFull Year Results
Beazley PLCHalf Year Results
Abcam PLCTrading Statement
Johnson Matthey PLCTrading Statement
Hellical PLCTrading Statement
GetBusy PLCHalf Year Results
Cohort PLCFull Year Results
Polymetal International PLCQ2 Production
Petra Diamonds LtdTrading Statement
Friday 24 July 
Hotel Chocolat Group PLCTrading Statement
IMI PLCInterim 2020 Results
Vodafone Group PLCQ1 2021 Trading Statement
CVS Group PLCTrading Statement
Centrica PLCInterim 2020 Results
Airtel Africa PlcQ1 2021 Results
PearsonHalf Year Results
Monday 27 July 
Ryanair Holdings PLCQ1 2021 Results
JTC PLCTrading Statement
Ascential PLCHalf Year Results
Tuesday 28 July 
Greggs PLCHalf Year Results
Sanne Group PLCTrading Statement
IMImobile PLCFull Year Results
IG Design Group PLCFull Year Results
Yourgene Health PLCFull Year Results
Quartix Holdings PLCHalf Year Results
Vivo Energy PLCHalf Year Results
MITIE Group PLCTrading Statement
MoneySupermarket.com Group PLCHalf Year Results
Tyman PLCHalf Year Results
Reckitt Benckiser Group PLCHalf Year Results
Greencore Group PLCTrading Statement
Elementis PLCHalf Year Results
Sabre Insurance Group PLCHalf Year Results
Virgin Money UK PLCTrading Statement
Games Workshop GroupFull Year Results
Fresnillo PLCHalf Year Results
St James's Place PLCHalf Year Results
Wednesday 29 July 
Aptitude Software Group PLCHalf Year Results
Aston Martin Lagonda Global Holdings PLCHalf Year Results
Aveva Group PLCTrading Statement
Barclays PLCHalf Year Results
Breedon Group PLCHalf Year Results
Devro PLCHalf Year Results
Dignity PLCHalf Year Results
Drax Group PLCHalf Year Results
FDM Group Holdings PLCHalf Year Results
GlaxoSmithKline PLCHalf Year Results
Horizon Discovery Group PLCHalf Year Results
Hyve Group PLCTrading Statement
Jupiter Fund Management PLCHalf Year Results
Lancashire Holdings PLCQ2 Results
Next PLCTrading Statement
Premier Foods PLCTrading Statement
Primary Health PropertiesHalf Year Results
Rathbone BrothersHalf Year Results
Rio Tinto PLCHalf Year Results
Seplat Petroleum Development Co PLCHalf Year Results
Smith & Nephew PLCHalf Year Results
Smurfit Kappa Group PLCHalf Year Results
Taylor WimpeyHalf Year Results
Tullow OilTrading Statement
Unite Group PLCHalf Year Results
Victoria PLCFull Year Results
Walker Greenbank PLCTrading Statement
Weir Group PLCHalf Year Results
Wizz Air Holdings PLCQ1 Results
  
Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
25 Sep 2023 08:37

TOP NEWS: GSK's Arexvy vaccine approved for adults over 60 in Japan

(Alliance News) - GSK PLC on Monday said the Japan Ministry of Health, Labour & Welfare has approved Arexvy for adults over 60.

Read more
25 Sep 2023 07:28

GSK's RSV vaccine gets approval in Japan

(Sharecast News) - GSK announced on Monday that its vaccine, Arexvy, has received approval from Japan's Ministry of Health, Labour and Welfare (MHLW) for preventing respiratory syncytial virus (RSV) disease in adults aged 60 and over.

Read more
19 Sep 2023 09:30

GSK says new HIV PrEP medication authorised by European Commission

(Alliance News) - GSK PLC on Tuesday said the European Commission has authorised ViiV Healthcare's "superior" drug Apretude to reduce the risk of sexually acquired HIV-1 infection.

Read more
18 Sep 2023 09:40

LONDON BROKER RATINGS: Jefferies likes Energean; JPMorgan raises IDS

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning:

Read more
18 Sep 2023 07:57

LONDON BRIEFING: Phoenix Group hails "impressive" first-half

(Alliance News) - Stocks in London are called lower on Monday, as investors focus on the week's upcoming central bank decisions.

Read more
18 Sep 2023 07:18

US FDA approves GSK treatment for myelofibrosis

(Sharecast News) - GSK announced on Monday that the US Food and Drug Administration (FDA) has granted approval for 'Ojjaara', or momelotinib, as a treatment for adults suffering from intermediate or high-risk myelofibrosis with anaemia, including cases of primary myelofibrosis or secondary myelofibrosis.

Read more
15 Sep 2023 21:52

GSK's Ojjaara approved in US for myelofibrosis patients with anaemia

(Alliance News) - GSK PLC on Friday said Ojjaara, also known as momelotinib, has been approved in the US and the "first and only" treatment indicated for myelofibrosis patients with anaemia.

Read more
11 Sep 2023 08:24

Japan accepts GSK's regulatory filing for momelotinib for blood cancer

(Alliance News) - GSK PLC on Monday reported regulatory progress for momelotinib, as Japan's Ministry of Health, Labour & Welfare accepted a review for the blood cancer-focused drug.

Read more
11 Sep 2023 07:54

LONDON BRIEFING: Restaurant Group sells Frankie & Benny's and Chiquito

(Alliance News) - Stocks in London are called higher on Monday, ahead of a busy week of interest rate decisions and economic data.

Read more
6 Sep 2023 09:32

LONDON BROKER RATINGS: Shore says 'buy' B&M; Peel Hunt likes Halfords

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning:

Read more
4 Sep 2023 06:00

More UK babies to need hospital treatment over delay of GSK's RSV jab

(Alliance News) - The nation's top children's doctor has warned a delay on a new vaccine to combat respiratory syncytial virus, or RSV, will mean more babies and infants will need hospital treatment this winter.

Read more
1 Sep 2023 09:11

GSK antibody accepted for Japan review, Goldman Sachs reduces stake

(Alliance News) - GSK PLC on Friday said a new drug application for its monoclonal antibody mepolizumab has been accepted for review by the Japanese government.

Read more
1 Sep 2023 07:49

LONDON BRIEFING: Stocks seen higher; UK house prices continue to fall

(Alliance News) - Stocks in London are set to open higher on Friday as markets looked ahead to a data-heavy day.

Read more
1 Sep 2023 07:12

Japan considering GSK's Nucala drug for sinusitis treatment

(Sharecast News) - Japanese regulators are reviewing a new drug application for GSK's Nucala treatment to be used for the treatment of form of adult sinusitis, the biopharma giant announced on Friday.

Read more
23 Aug 2023 12:10

LONDON MARKET MIDDAY: Stocks rise but pound slumps on sub-par UK data

(Alliance News) - Stocks in Europe were on the up heading into Wednesday afternoon, with equity markets in a confident mood on the eve of the Jackson Hole central banking event, shaking off tepid economic data which hurt the pound and euro.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.